Biphenotypic Acute Leukemia
📧 Sign up to get email alerts when something new happens for Biphenotypic Acute Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-24Clinical Trial Update: Cryopreserved MMUD BM With PTCy for Hematologic Malignancies [Phase 1]
Phase 1 trial of cryopreserved MMUD bone marrow with post-transplant cyclophosphamide for hematologic malignancies has been withdrawn.
-
CLINICAL_TRIALS other · 2025-04-29Clinical Trial Update: MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing [NA]
Clinical trial update from the Medical College of Wisconsin describes a study using targeted antithymocyte globulin dosing to deplete alpha/…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis [Phase 3]
Phase 3 clinical trial evaluating a post-transplant immunomodulatory regimen (cyclophosphamide, abatacept, vedolizumab, and a calcineurin in…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Acute Lymphoblastic Leukemia Registry at Asan Medical Center
The Acute Lymphoblastic Leukemia Registry trial at Asan Medical Center has been terminated.